Lu Yan Selected Research

Lu Yan Research Topics

Disease

24	Neoplasms (Cancer) 05/2021 - 05/2004
8	Pulmonary Hypertension 01/2022 - 11/2019
6	Inflammation (Inflammations) 03/2018 - 07/2012
5	Melanoma (Melanoma, Malignant) 09/2019 - 07/2015
4	Hypoxia (Hypoxemia) 11/2021 - 01/2018
4	Stomach Neoplasms (Stomach Cancer) 12/2014 - 12/2010
3	Wounds and Injuries (Trauma) 06/2021 - 07/2020
3	Liver Cirrhosis (Hepatic Cirrhosis) 01/2021 - 12/2011
2	Body Weight (Weight, Body) 06/2022 - 07/2012
2	Neurodegenerative Diseases (Neurodegenerative Disease) 01/2022 - 01/2021
2	Infections 10/2021 - 02/2017
2	Hepatocellular Carcinoma (Hepatoma) 05/2021 - 11/2014
2	Heart Failure 01/2021 - 01/2020
2	Neoplasm Metastasis (Metastasis) 01/2014 - 11/2013
2	Granuloma 04/2012 - 12/2011
1	Lung Injury 01/2022
1	Strabismus (Squint) 01/2022
1	Clinical Deterioration 01/2022
1	Gastroesophageal Reflux (GERD) 01/2022
1	Hypertension (High Blood Pressure) 01/2022
1	Chronic Obstructive Pulmonary Disease (COPD) 01/2022
1	Lung Diseases (Lung Disease) 11/2021
1	Muscular Diseases (Myopathy) 11/2021
1	Muscular Dystrophies (Muscular Dystrophy) 11/2021
1	Tauopathies 10/2021
1	Death (Near-Death Experience) 02/2021
1	Huntington Disease (Huntington's Disease) 01/2021
1	Nephritis 01/2021
1	Pericardial Effusion 01/2021
1	Alzheimer Disease (Alzheimer's Disease) 01/2021
1	Lupus Nephritis 01/2021
1	Neuroinflammatory Diseases 01/2021
1	Parkinson Disease (Parkinson's Disease) 01/2021
1	Cardiovascular Diseases (Cardiovascular Disease) 11/2020
1	Systemic Scleroderma (Systemic Sclerosis) 11/2020
1	Glioma (Gliomas) 08/2020
1	Cicatrix (Scar) 07/2020

Drug/Important Bio-Agent (IBA)

10	Proteins (Proteins, Gene)FDA Link 01/2021 - 08/2006
5	Biomarkers (Surrogate Marker)IBA 01/2022 - 10/2015
4	CytokinesIBA 07/2020 - 07/2012
4	Long Noncoding RNAIBA 03/2020 - 01/2019
3	Oxygen (Dioxygen)IBA 11/2021 - 01/2018
3	AntigensIBA 01/2021 - 07/2015
3	Messenger RNA (mRNA)IBA 11/2019 - 01/2014
3	GraphiteIBA 09/2019 - 01/2018
3	MicellesIBA 02/2015 - 10/2008
2	EnzymesIBA 10/2020 - 10/2020
2	VaccinesIBA 12/2019 - 07/2015
2	AntioxidantsIBA 11/2019 - 01/2018
2	Peptides (Polypeptides)IBA 09/2019 - 07/2015
2	Antineoplastic Agents (Antineoplastics)IBA 09/2019 - 01/2018
2	Small Interfering RNA (siRNA)IBA 01/2018 - 01/2016
2	LipopolysaccharidesIBA 01/2017 - 10/2016
2	Cyclin D1IBA 01/2016 - 01/2014
2	OsteopontinIBA 04/2012 - 12/2011
1	lead acetateIBA 06/2022
1	Uric Acid (Urate)IBA 01/2022
1	Neuroprotective AgentsIBA 01/2022
1	Mitochondrial Proteins (Mitochondrial Protein)IBA 01/2022
1	PolyphenolsIBA 01/2022
1	Formaldehyde (Formol)FDA Link 01/2022
1	4-S-(propionic acid)sulfidocyclophosphamide (PASP)IBA 01/2022
1	Air Pollutants (Pollutants, Air)IBA 01/2022
1	Proton Pump InhibitorsIBA 01/2022
1	Minocycline (Cyclops)FDA LinkGeneric 01/2022
1	AcidsIBA 01/2022
1	Interferon Type IIBA 10/2021
1	SilverIBA 06/2021
1	iturin AIBA 05/2021
1	omega-Chloroacetophenone (Mace)IBA 02/2021
1	CM 2-3IBA 02/2021
1	Phosphatidylinositols (Phosphatidylinositol)IBA 01/2021
1	Phosphoric Monoester Hydrolases (Phosphatases)IBA 01/2021
1	Clostridium perfringens epsilon-toxinIBA 01/2021
1	Carbon MonoxideIBA 01/2021
1	CarbohydratesIBA 01/2021
1	TensinsIBA 01/2021
1	Immunoglobulin G (IgG)IBA 01/2021
1	Leucine (L-Leucine)FDA Link 01/2021
1	SterolsIBA 01/2021
1	anti-dsDNA autoantibodyIBA 01/2021
1	Bile Acids and Salts (Bile Acids)IBA 01/2021
1	pro-brain natriuretic peptide (1-76)IBA 01/2021
1	NucleotidesIBA 01/2021
1	Reactive Oxygen Species (Oxygen Radicals)IBA 01/2021
1	XenobioticsIBA 01/2021
1	CreatinineIBA 01/2021
1	InflammasomesIBA 01/2021
1	mesoglycanIBA 11/2020
1	MetalsIBA 10/2020
1	PolymersIBA 10/2020
1	Volatile Oils (Essential Oils)IBA 08/2020
1	surfactin AIBA 07/2020

Therapy/Procedure

15	Therapeutics 10/2021 - 04/2013
3	Drug Therapy (Chemotherapy) 01/2022 - 01/2016
3	Lasers (Laser) 02/2021 - 02/2015
2	Endarterectomy (Thromboendarterectomy) 01/2021 - 11/2019
2	Photothermal Therapy 10/2020 - 02/2015
1	Cell- and Tissue-Based Therapy (Cell Therapy) 11/2021
1	Transplantation 01/2021